Levetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
Levetiracetamum
Levetiracetame
Lévétiracetam
Levetiracetam
Brand Names
Levetiracetam extended-release
Dom-levetiracetam
PMS-levetiracetam
Abbott-levetiracetam
Jamp-levetiracetam
Matever
Levetiracetam 750 mg
Levetiracetam Accord
Levetiracetam Micro
Levetiracetam 1000 mg
Levetiracetam
Levetiracetam Levetiracetam
Ava-levetiracetam
Priva-levetiracetam
PHL-levetiracetam
Ach-levetiracetam
M-levetiracetam
Levetiracetam Hospira
Torrent-levetiracetam
Pharma-levetiracetam
Bio-levetiracetam
Levetiracetam Injection USP
Levetiracetam Extended-release
Levetiracetam Extended-Release
Levetiracetam Teva
Riva-levetiracetam
Levetiracetam 250 mg
Elepsia XR
Tva-levetiracetam
Teva-levetiracetam
Pro-levetiracetam - 750
Levetiracetam ER
Ran-levetiracetam
Pro-levetiracetam - 250
Apo-levetiracetam
Nat-levetiracetam
Roweepra XR
Van-levetiracetam
Levetiracetam Sun
LEVETIRACETAM solution
Pro-levetiracetam - 500
Ag-levetiracetam
Levetiracetam Actavis
Levetiracetam Actavis Group
Novo-levetiracetam
Levetiracetam in Sodium Chloride
Levetiractam
Jamp Levetiracetam Tablets
Levetiracetam Ratiopharm
Nu-levetiracetam
Keppra XR
Roweepra
Spritam
Keppra
Auro-levetiracetam
Levertiracetam
Mint-levetiracetam
Nra-levetiracetam
Mint-levetiracetam Solution
LEVETIRACETAM Extended-release
Elepsia XR 1000 mg
Pdp-levetiracetam
Levetiracetam Extended Release
Sandoz Levetiracetam
Elepsia XR 1500 mg
Indication
Levetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
Acetamides
Amides
Anticonvulsants
Central Nervous System Agents
Central Nervous System Depressants
Decreased Central Nervous System Disorganized Electrical Activity
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682